Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>KH Neochem is a specialized Japanese chemical manufacturer with a diversified portfolio serving resilient and high-growth end-markets such as electronics, automotive, and cosmetics.</li>
 <li>The company demonstrates a strong commitment to shareholder returns, evidenced by a high dividend yield, consistent dividend growth, and a recently enhanced payout policy including share buybacks.</li>
 <li>Despite near-term headwinds from soft domestic demand and import competition, the company's focus on high-purity, value-added products and R&amp;D investments positions it for a potential profit recovery and long-term growth.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  KH Neochem is a specialized Japanese chemical manufacturer with a diversified portfolio serving resilient and high-growth end-markets such as electronics, automotive, and cosmetics.
  The company demonstrates a strong commitment to shareholder returns, evidenced by a high dividend yield, consistent dividend growth, and a recently enhanced payout policy including share buybacks.
  Despite near-term headwinds from soft domestic demand and import competition, the company's focus on high-purity, value-added products and R&amp;D investments positions it for a potential profit recovery and long-term growth.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: KH Neochem Co Ltd (4189 JP) - Feb 2026

Japanese Turnaround Situations, Short-Ideas, Azabu Research

Michael Allen

Japanese Turnaround Situations, Short-Ideas

Azabu Research

Azabu Research is a publishing and consulting firm focused on distressed equities in the Japanese market. We specialize in turnaround strategies, corporate combinations, divestitures, and restructuring.

Publisher of the Tokyo Turnaround Letter, which conducts the most thorough research possible of publicly available information, including forensic tests for fraudulent overstatement of assets and understatement of liabilities, as well as rigorous market and industry analysis to assess the underlying strengths of the company’s products or services, the appropriateness of the company’s turnaround strategy, and the skill of its current management team. The average length of a report exceeds 25 pages of text and tables, excluding any disclosures or executive summaries.

We have more than 30 years of experience in applying this process to distressed equities in Japan. Additionally, subscribers have free access to detailed, yet easily navigated earnings models for the target company as well as the top five comparable companies, and unlimited access to the analyst for follow-up questions.

Azabu Research also conducts be-spoke research on a project basis, and provides consulting services to companies looking to restructure, divest, make acquisitions, go public, or improve investor sentiment toward their stock.

Independent Research and Consulting Firm

<ul>
<li>Japan’s chemicals industry is finally undergoing a long-overdue consolidation that should lead to fewer companies, higher profitability, and less volatility.</li>
<li>These changes may be driving significant mispricing. Like most segments, RoE drives most of the variance in PBR, but with more frequent and far larger outliers.</li>
<li>KH Neochem, Daicel, and Mitsui Chemicals are the undervalued outliers, and all three are positioned for rapid growth in our view.</li>
</ul>


Japan’s chemicals industry is finally undergoing a long-overdue consolidation that should lead to fewer companies, higher profitability, and less volatility.
These changes may be driving significant mispricing. Like most segments, RoE drives most of the variance in PBR, but with more frequent and far larger outliers.
KH Neochem, Daicel, and Mitsui Chemicals are the undervalued outliers, and all three are positioned for rapid growth in our view.


Long-Overdue Consolidation in Japanese Chemicals Drives Growth & Mispricing

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/lintec-corp" target="_blank" data-smartkarma-citation="entities:5564:1" rel="noopener">Lintec Corp (7966 JP)</a> is a maker of printed adhesives, stickers, seals, labels, barcodes strips, etc. They also do adhesives for optical products and LCDs/electronics. That's 80-90% of OP.</li>
<li>
<a href="https://www.smartkarma.com/entities/nippon-paper-industries-co-l" target="_blank" data-smartkarma-citation="entities:557:1" rel="noopener">Nippon Paper Industries Co L (3863 JP)</a> owns 32%. Today they announced they are selling 30%, worth ¥112bn or so at last price. It's big. 60x ADV. </li>
<li>Lintec today announced Q1 earnings, which are probably a trifle light. They also announced a buyback of up to 10.55% of shares to mitigate the impact of the offering. Better.</li>
</ul>



Lintec Corp (7966 JP) is a maker of printed adhesives, stickers, seals, labels, barcodes strips, etc. They also do adhesives for optical products and LCDs/electronics. That's 80-90% of OP.

Nippon Paper Industries Co L (3863 JP) owns 32%. Today they announced they are selling 30%, worth ¥112bn or so at last price. It's big. 60x ADV. 
Lintec today announced Q1 earnings, which are probably a trifle light. They also announced a buyback of up to 10.55% of shares to mitigate the impact of the offering. Better.


[Japan Offering] Nippon Paper Selling 30% of Lintec (7966 JP) - Big Offering W/ Offsetting Buyback

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report we take a bottoms-up view on developed ex-U.S. equities, highlighting stocks that present attractive buy opportunities within the Communications, Health Care, Manufacturing, Materials, Technology, Transportation, and Utilities Sectors

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report we take a bottoms-up view on developed ex-U.S. equities, highlighting stocks that present attractive buy opportunities within the Communications, Health Care, Manufacturing, Materials, Technology, Transportation, and Utilities Sectors

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in margin trading positions of JPX stocks as of Mar 27th. The aggregated net margin trading position is USD17,856m.</li>
<li>We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.</li>
<li>We highlight net margin buy/sell changes in Fujikura, SoftBank, Sanrio, West Japan Railway Company, Advantest, Kioxia, Honda Motor, Kyushu Railway Company, Sumitomo Metal Mining, SBI.</li>
</ul>


We analyzed the changes in margin trading positions of JPX stocks as of Mar 27th. The aggregated net margin trading position is USD17,856m.
We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
We highlight net margin buy/sell changes in Fujikura, SoftBank, Sanrio, West Japan Railway Company, Advantest, Kioxia, Honda Motor, Kyushu Railway Company, Sumitomo Metal Mining, SBI.


JPX Margin Trading Weekly (Mar 27th): Fujikura, SoftBank, Sanrio, West Japan Railway Company

Japan

KH Neochem Co., Ltd. manufactures and sells petroleum chemical products.  The Company mainly focuses the business lines including Basic Chemicals, Performance materials and Electronic materials.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

KH Neochem Co Ltd (4189 JP)

Primer: KH Neochem Co Ltd (4189 JP) - Feb 2026

KH Neochem is a specialized Japanese chemical manufacturer with a diversified portfolio serving resilient and high-growth end-markets such as...

αSK Primers

Long-Overdue Consolidation in Japanese Chemicals Drives Growth & Mispricing

Consolidation in Japan's chemicals industry leading to fewer companies, higher profitability, and potential for growth in undervalued outliers...

Michael Allen

[Japan Offering] Nippon Paper Selling 30% of Lintec (7966 JP) - Big Offering W/ Offsetting Buyback

Nippon Paper is selling 30% (almost its entire stake) of Lintec. This may be a surprise to some who might have expected a take-private. It's a big...

Travis Lundy

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index. In today’s report...

Vermilion Research

JPX Margin Trading Weekly (Mar 27th): Fujikura, SoftBank, Sanrio, West Japan Railway Company

We analyzed JPX margin trading positions report for the past week and highlighted Fujikura (5803 JP), SoftBank (9984 JP), Sanrio (8136 JP), West...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Primer: KH Neochem Co Ltd (4189 JP) - Feb 2026

KH Neochem is a specialized Japanese chemical manufacturer with a diversified portfolio serving resilient and high-growth end-markets such as...

αSK Primers

Long-Overdue Consolidation in Japanese Chemicals Drives Growth & Mispricing

​Consolidation in Japan's chemicals industry leading to fewer companies, higher profitability, and potential for growth in undervalued outliers...

Michael Allen

[Japan Offering] Nippon Paper Selling 30% of Lintec (7966 JP) - Big Offering W/ Offsetting Buyback

Nippon Paper is selling 30% (almost its entire stake) of Lintec. This may be a surprise to some who might have expected a take-private. It's a big...

Travis Lundy

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index. In today’s report...

Vermilion Research

JPX Margin Trading Weekly (Mar 27th): Fujikura, SoftBank, Sanrio, West Japan Railway Company

We analyzed JPX margin trading positions report for the past week and highlighted Fujikura (5803 JP), SoftBank (9984 JP), Sanrio (8136 JP), West...

Ke Yan, CFA, FRM

Consolidation in Japan's chemicals industry leading to fewer companies, higher profitability, and potential for growth in undervalued outliers...